NCT02094742View on ClinicalTrials.gov

BIG Molecular Screening Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Metastatic Breast Cancer
Interventions
PROCEDURE

biopsy

Trial Locations (4)

1000

Institut Jules Bordet, Brussels

Unknown

Klinikum Offenbach, Offenbach

Val d'Hebron, Barcelona

University Hospital, Dundee

Sponsors
All Listed Sponsors
collaborator

Breast International Group

OTHER

lead

Jules Bordet Institute

OTHER